Impaired Sulfate Metabolism and Epigenetics: Is There a Link in Autism?

Autism is a brain disorder involving social, memory, and learning deficits, that normally develops prenatally or early in childhood. Frustratingly, many research dollars have as yet failed to identify the cause of autism. While twin concordance studies indicate a strong genetic component, the alarming rise in the incidence of autism in the last three decades suggests that environmental factors play a key role as well. This dichotomy can be easily explained if we invoke a heritable epigenetic effect as the primary factor. Researchers are just beginning to realize the huge significance of epigenetic effects taking place during gestation in influencing the phenotypical expression. Here, we propose the novel hypothesis that sulfates deficiency in both the mother and the child, brought on mainly by excess exposure to environmental toxins and inadequate sunlight exposure to the skin, leads to widespread hypomethylation in the fetal brain with devastating consequences. We show that many seemingly disparate observations regarding serum markers, neuronal pathologies, and nutritional deficiencies associated with autism can be integrated to support our hypothesis.

[1]  H. Nader,et al.  Distribution of sulfated glycosaminoglycans in the animal kingdom: widespread occurrence of heparin-like compounds in invertebrates. , 2000, Biochimica et biophysica acta.

[2]  Mark Lucock,et al.  G80A reduced folate carrier SNP modulates cellular uptake of folate and affords protection against thrombosis via a non homocysteine related mechanism. , 2005, Life sciences.

[3]  Suzanne McDermott,et al.  Pre-Eclampsia, Birth Weight, and Autism Spectrum Disorders , 2010, Journal of autism and developmental disorders.

[4]  Clive Osmond,et al.  Impaired Insulin Secretion After Prenatal Exposure to the Dutch Famine A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances. , 2006, Diabetes Care.

[5]  Karoly Horvath,et al.  Autism and gastrointestinal symptoms , 2002, Current gastroenterology reports.

[6]  Lisa M Bodnar,et al.  Maternal vitamin D deficiency increases the risk of preeclampsia. , 2007, The Journal of clinical endocrinology and metabolism.

[7]  Mark D. Shriver,et al.  The 8818G allele of the agouti signaling protein (ASIP) gene is ancestral and is associated with darker skin color in African Americans , 2005, Human Genetics.

[8]  David W Gaylor,et al.  Abnormal Transmethylation/transsulfuration Metabolism and DNA Hypomethylation Among Parents of Children with Autism , 2008, Journal of autism and developmental disorders.

[9]  Charles E. Schwartz,et al.  High frequency of neurexin 1β signal peptide structural variants in patients with autism , 2006, Neuroscience Letters.

[10]  H. M. Geller,et al.  Chondroitin sulfate proteoglycans in neural development and regeneration , 2005, Current Opinion in Neurobiology.

[11]  P. Whiteley,et al.  Biochemical aspects in autism spectrum disorders: updating the opioid-excess theory and presenting new opportunities for biomedical intervention , 2002, Expert opinion on therapeutic targets.

[12]  Linda C. Schmidt,et al.  Prenatal Vitamins, One-carbon Metabolism Gene Variants, and Risk for Autism , 2011, Epidemiology.

[13]  Konstantinos Francis,et al.  Novel therapeutic targets for autism. , 2008, Trends in pharmacological sciences.

[14]  D. Laraque,et al.  Autism and developmental abnormalities in children with perinatal cocaine exposure. , 1992, Journal of the National Medical Association.

[15]  N. Klein,et al.  Disruption of sulphated glycosaminoglycans in intestinal inflammation , 1993, The Lancet.

[16]  K. Mccully,et al.  Chemical pathology of homocysteine. V. Thioretinamide, thioretinaco, and cystathionine synthase function in degenerative diseases. , 2011, Annals of clinical and laboratory science.

[17]  R. Deth,et al.  How environmental and genetic factors combine to cause autism: A redox/methylation hypothesis. , 2008, Neurotoxicology.

[18]  W. Sessa,et al.  Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough? , 2001, The Journal of pharmacology and experimental therapeutics.

[19]  Tanya M. Teslovich,et al.  A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. , 2008, American journal of human genetics.

[20]  Christopher Gillberg,et al.  Prevalence of autism in children born to Somali parents living in Sweden: a brief report , 2008, Developmental medicine and child neurology.

[21]  C. Falany,et al.  Expression and Localization of Cytosolic Sulfotransferase (SULT) 1A1 and SULT1A3 in Normal Human Brain , 2009, Drug Metabolism and Disposition.

[22]  Kim L R Brouwer,et al.  Integration of hepatic drug transporters and phase II metabolizing enzymes: mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione metabolites. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[23]  Patricia M. Whitaker-Azmitia,et al.  Behavioral and cellular consequences of increasing serotonergic activity during brain development: a role in autism? , 2005, International Journal of Developmental Neuroscience.

[24]  Takuya Takizawa,et al.  The Efflux Transport of Dehydroepiandrosterone Sulfate at the Blood-Brain Barrier , 2000 .

[25]  Stefano Bonassi,et al.  Oxidative stress-related biomarkers in autism: systematic review and meta-analyses. , 2012, Free radical biology & medicine.

[26]  Rubina A Karatela,et al.  Plasma homocysteine in obese, overweight and normal weight hypertensives and normotensives. , 2009, Indian heart journal.

[27]  W. Dröge,et al.  Glutathione and immune function , 2000, Proceedings of the Nutrition Society.

[28]  E. Mosharov,et al.  The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the transsulfuration pathway and its regulation by redox changes. , 2000, Biochemistry.

[29]  Stephanie Seneff,et al.  Might cholesterol sulfate deficiency contribute to the development of autistic spectrum disorder? , 2012, Medical hypotheses.

[30]  A. Chauhan,et al.  Oxidative stress in autism. , 2006, Pathophysiology : the official journal of the International Society for Pathophysiology.

[31]  K. Muegge,et al.  DNA methylation in early development , 2010, Molecular reproduction and development.

[32]  George M. Anderson,et al.  Urinary 5-hydroxyindoleacetic acid and whole blood serotonin and tryptophan in autistic and normal subjects , 1987, Biological Psychiatry.

[33]  C. Barthélémy,et al.  Vitamin B6, magnesium, and combined B6-Mg: Therapeutic effects in childhood autism , 1985, Biological Psychiatry.

[34]  Carl Feinstein,et al.  Oxytocin and autistic disorder: alterations in peptide forms , 2001, Biological Psychiatry.

[35]  David A Geier,et al.  A prospective assessment of androgen levels in patients with autistic spectrum disorders: biochemical underpinnings and suggested therapies. , 2007, Neuro endocrinology letters.

[36]  Caroline A. Macera,et al.  Acetaminophen (paracetamol) use, measles-mumps-rubella vaccination, and autistic disorder , 2008, Autism : the international journal of research and practice.

[37]  R L Blaylock,et al.  Immune-glutamatergic dysfunction as a central mechanism of the autism spectrum disorders. , 2009, Current medicinal chemistry.

[38]  A. Beitz,et al.  Intrathecal injection of the neurosteroid, DHEAS, produces mechanical allodynia in mice: involvement of spinal sigma‐1 and GABAA receptors , 2009, British journal of pharmacology.

[39]  Ping Zhu,et al.  Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells , 2001, The EMBO journal.

[40]  R Day,et al.  Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. , 2001, The Journal of pediatrics.

[41]  D. Williams,et al.  Membrane cholesterol modulates serotonin transporter activity. , 2001, Biochemistry.

[42]  Paul A Dawson,et al.  Sulfate in fetal development. , 2011, Seminars in cell & developmental biology.

[43]  Hieronim Jakubowski,et al.  The role of paraoxonase 1 in the detoxification of homocysteine thiolactone. , 2010, Advances in experimental medicine and biology.

[44]  Tianyan Zhou,et al.  Genistein induction of human sulfotransferases in HepG2 and Caco-2 cells. , 2008, Basic & clinical pharmacology & toxicology.

[45]  D. Markovich,et al.  Identification of a mammalian brain sulfate transporter. , 1999, Biochemical and biophysical research communications.

[46]  Paul A Dawson,et al.  NaSi-1 and Sat-1: structure, function and transcriptional regulation of two genes encoding renal proximal tubular sulfate transporters. , 2005, The international journal of biochemistry & cell biology.

[47]  L. Allen,et al.  Causes of Vitamin B12 and Folate Deficiency , 2008, Food and nutrition bulletin.

[48]  A. Ylinen,et al.  Reg1ulatory Role and Molecular Interactions of a Cell-Surface Heparan Sulfate Proteoglycan (N-syndecan) in Hippocampal Long-Term Potentiation , 1999, The Journal of Neuroscience.

[49]  J. Wilkinson,et al.  The role of the agouti gene in the yellow obese syndrome. , 1997, The Journal of nutrition.

[50]  Donna Spiegelman,et al.  Prenatal risk factors for autism: comprehensive meta-analysis , 2009, British Journal of Psychiatry.

[51]  N. Jiang,et al.  Inhibition of nitric oxide synthase by cobalamins and cobinamides. , 2009, Free radical biology & medicine.

[52]  W. Grant,et al.  Epidemiologic evidence for supporting the role of maternal vitamin D deficiency as a risk factor for the development of infantile autism , 2009, Dermato-endocrinology.

[53]  Takeshi Sakurai,et al.  The emerging role of synaptic cell-adhesion pathways in the pathogenesis of autism spectrum disorders , 2009, Trends in Neurosciences.

[54]  Pei-Hua Lu,et al.  [Chondroitin sulfate proteoglycans in neural development and regeneration]. , 2007, Sheng li ke xue jin zhan [Progress in physiology].

[55]  Yuko Higashi,et al.  Cholesterol sulfate in human physiology: what's it all about? , 2003, Journal of lipid research.

[56]  A Braconnier,et al.  Serotonin metabolism and other biochemical parameters in infantile autism. A controlled study of 22 autistic children. , 1988, Neuropsychobiology.

[57]  Janet K. Kern,et al.  A Prospective Study of Transsulfuration Biomarkers in Autistic Disorders , 2009, Neurochemical Research.

[58]  S. Nozawa,et al.  Alteration of acidic lipids in human sera during the course of pregnancy: characteristic increase in the concentration of cholesterol sulfate. , 1997, Journal of chromatography. B, Biomedical sciences and applications.

[59]  H. Takanaga,et al.  Blood—Brain Barrier Is Involved in the Efflux Transport of a Neuroactive Steroid, Dehydroepiandrosterone Sulfate, via Organic Anion Transporting Polypeptide 2 , 2000, Journal of neurochemistry.

[60]  W. B. van den Berg,et al.  High susceptibility of human articular cartilage glycosaminoglycan synthesis to changes in inorganic sulfate availability , 1990, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[61]  A. Polge,et al.  Improvement of neurobehavioral disorders in children supplemented with magnesium-vitamin B6. II. Pervasive developmental disorder-autism. , 2006, Magnesium research.

[62]  A. Polge,et al.  Improvement of neurobehavioral disorders in children supplemented with magnesium-vitamin B6. I. Attention deficit hyperactivity disorders. , 2006, Magnesium research.

[63]  J. Sebat,et al.  Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. , 2008, American journal of human genetics.

[64]  Guoping Fan,et al.  DNA methylation controls the timing of astrogliogenesis through regulation of JAK-STAT signaling , 2005, Development.

[65]  R. Waring,et al.  Enzyme and sulphur oxidation deficiencies in autistic children with known food intolerances. , 1993 .

[66]  D. Dolinoy,et al.  The agouti mouse model: an epigenetic biosensor for nutritional and environmental alterations on the fetal epigenome. , 2008, Nutrition reviews.

[67]  B. Nemeș,et al.  High levels of homocysteine and low serum paraoxonase 1 arylesterase activity in children with autism. , 2006, Life sciences.

[68]  Marko Kaksonen,et al.  Syndecan-3-Deficient Mice Exhibit Enhanced LTP and Impaired Hippocampus-Dependent Memory , 2002, Molecular and Cellular Neuroscience.

[69]  P. Ashwood,et al.  The immune response in autism: a new frontier for autism research , 2006, Journal of leukocyte biology.

[70]  E R Martin,et al.  Association Analysis of Chromosome 15 GABAA Receptor Subunit Genes in Autistic Disorder , 2001, Journal of neurogenetics.

[71]  Abraham Weizman,et al.  Lowered DHEA-S plasma levels in adult individuals with autistic disorder , 2005, European Neuropsychopharmacology.

[72]  C. Falany,et al.  Mapping of the phenol sulfotransferase gene (STP) to human chromosome 16p12.1-p11.2 and to mouse chromosome 7. , 1993, Genomics.

[73]  Lutz Edler,et al.  Improvement of immune functions in HIV infection by sulfur supplementation: Two randomized trials , 2000, Journal of Molecular Medicine.

[74]  Ruma Banerjee,et al.  Testosterone regulation of homocysteine metabolism modulates redox status in human prostate cancer cells. , 2007, Antioxidants & redox signaling.

[75]  A. El-Ansary,et al.  Novel metabolic biomarkers related to sulfur-dependent detoxification pathways in autistic patients of Saudi Arabia , 2011, BMC neurology.

[76]  Otilia Catanescu,et al.  Homocysteine is transported by the microvillous plasma membrane of human placenta , 2011, Journal of Inherited Metabolic Disease.

[77]  W. Reik Stability and flexibility of epigenetic gene regulation in mammalian development , 2007, Nature.

[78]  Henry Markram,et al.  Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid , 2007, Proceedings of the National Academy of Sciences.

[79]  I. Korf,et al.  Large-scale methylation domains mark a functional subset of neuronally expressed genes. , 2011, Genome research.

[80]  V. Rakyan,et al.  Transgenerational inheritance of epigenetic states at the murine AxinFu allele occurs after maternal and paternal transmission , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[81]  Ken Eagle,et al.  Toxicological effects of red wine, orange juice, and other dietary SULT1A inhibitors via excess catecholamines. , 2012, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[82]  Orit Pappo,et al.  Hepatic effects of rosiglitazone in rats with the metabolic syndrome. , 2010, Basic & clinical pharmacology & toxicology.

[83]  I. Pogribny,et al.  Intracellular S-adenosylhomocysteine concentrations predict global DNA hypomethylation in tissues of methyl-deficient cystathionine beta-synthase heterozygous mice. , 2001, The Journal of nutrition.

[84]  S. J. James,et al.  Cerebral folate receptor autoantibodies in autism spectrum disorder , 2012, Molecular Psychiatry.

[85]  Stepan Melnyk,et al.  Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[86]  E. Tierney,et al.  Cholesterol Deficit in Autism: Insights from Smith–Lemli–Opitz Syndrome , 2008 .

[87]  Robert T. Schultz,et al.  Common genetic variants on 5p14.1 associate with autism spectrum disorders , 2009, Nature.

[88]  A. Meister,et al.  Glutathione is required for intestinal function. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[89]  G. Stoner,et al.  Cholesterol sulfate accumulation in tumorigenic and nontumorigenic rat esophageal epithelial cells: evidence for defective differentiation control in tumorigenic cells. , 1988, Cancer research.

[90]  Y. Yamaguchi,et al.  Heparan sulfate proteoglycans in the nervous system: their diverse roles in neurogenesis, axon guidance, and synaptogenesis. , 2001, Seminars in cell & developmental biology.

[91]  C. Klaassen,et al.  Different mechanism of saturation of acetaminophen sulfate conjugation in mice and rats. , 1996, Toxicology and applied pharmacology.

[92]  Janet K. Kern,et al.  Biomarkers of environmental toxicity and susceptibility in autism , 2009, Journal of the Neurological Sciences.

[93]  Paula Krakowiak,et al.  Maternal Metabolic Conditions and Risk for Autism and Other Neurodevelopmental Disorders , 2012, Pediatrics.

[94]  Maurizio Elia,et al.  Sulphation deficit in “low-functioning” autistic children: a pilot study , 1999, Biological Psychiatry.

[95]  Janine M. LaSalle,et al.  A genomic point-of-view on environmental factors influencing the human brain methylome , 2011, Epigenetics.

[96]  Janet K. Kern,et al.  An evaluation of the role and treatment of elevated male hormones in autism spectrum disorders. , 2012, Acta neurobiologiae experimentalis.

[97]  Bess Dawson-Hughes,et al.  The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. , 2007, The Journal of clinical endocrinology and metabolism.

[98]  Keiji Morokuma,et al.  Zinc–Homocysteine binding in cobalamin‐dependent methionine synthase and its role in the substrate activation: DFT, ONIOM, and QM/MM molecular dynamics studies , 2011, J. Comput. Chem..

[99]  S. Mennerick,et al.  Hydrophobic anions potently and uncompetitively antagonize GABAA receptor function in the absence of a conventional binding site , 2011, British journal of pharmacology.

[100]  C. Klaassen,et al.  The importance of 3‘‐phosphoadenosine 5‘‐phosphosulfate (PAPS) in the regulation of sulfation , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[101]  Dennis P Wall,et al.  Heparan sulfate proteoglycans and the emergence of neuronal connectivity , 2006, Current Opinion in Neurobiology.

[102]  T. Kemper,et al.  Density and Distribution of Hippocampal Neurotransmitter Receptors in Autism: An Autoradiographic Study , 2001, Journal of autism and developmental disorders.

[103]  R. Waterland,et al.  Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. , 2004, Nutrition.

[104]  J. Baio Morbidity and Mortality Weekly Report Prevalence of Autism Spectrum Disorders — Autism and Developmental Disabilities Monitoring Network, Six Sites, United States, 2000; Prevalence of Autism Spectrum Disorders — Autism and Developmental Disabilities Monitoring Network, 14 Sites, United States, 2002; , 2007 .

[105]  Y. Yamaguchi,et al.  Autism-like socio-communicative deficits and stereotypies in mice lacking heparan sulfate , 2012, Proceedings of the National Academy of Sciences.

[106]  D. Conrad,et al.  Recurrent 16p11.2 microdeletions in autism. , 2007, Human molecular genetics.

[107]  Christian Biémont,et al.  Genetics: Junk DNA as an evolutionary force , 2006, Nature.

[108]  Stephanie Seneff,et al.  The Initial Common Pathway of Inflammation, Disease, and Sudden Death , 2012, Entropy.

[109]  David W. Gaylor,et al.  A functional polymorphism in the reduced folate carrier gene and DNA hypomethylation in mothers of children with autism , 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[110]  P. Grattan-Smith,et al.  The neurological syndrome of infantile cobalamin deficiency: Developmental regression and involuntary movements , 1997, Movement disorders : official journal of the Movement Disorder Society.

[111]  Janet K. Kern,et al.  A clinical trial of glutathione supplementation in autism spectrum disorders , 2011, Medical science monitor : international medical journal of experimental and clinical research.

[112]  A. Gürel,et al.  Nitric oxide as a physiopathological factor in neuropsychiatric disorders. , 2004, In vivo.

[113]  Paul T Martin,et al.  Glycobiology of the synapse. , 2002, Glycobiology.

[114]  L. Matherly,et al.  Molecular and cellular biology of the human reduced folate carrier. , 2001, Progress in nucleic acid research and molecular biology.

[115]  Victoria Arija,et al.  Maternal homocysteine before conception and throughout pregnancy predicts fetal homocysteine and birth weight. , 2004, Clinical chemistry.

[116]  David W Gaylor,et al.  Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. , 2004, The American journal of clinical nutrition.

[117]  H. Savaş,et al.  Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[118]  J. Mason,et al.  Activation of methionine synthase by insulin-like growth factor-1 and dopamine: a target for neurodevelopmental toxins and thimerosal , 2004, Molecular Psychiatry.

[119]  Wei Zheng,et al.  Critical role of vitamin D in sulfate homeostasis: regulation of the sodium-sulfate cotransporter by 1,25-dihydroxyvitamin D3. , 2004, American journal of physiology. Endocrinology and metabolism.

[120]  Leslie Roberts,et al.  Controversial From the Start , 2001, Science.

[121]  Mari S Golub,et al.  Long-lived epigenetic interactions between perinatal PBDE exposure and Mecp2308 mutation. , 2012, Human molecular genetics.

[122]  Marwan Shinawi,et al.  The MTHFR 677C→T polymorphism and behaviors in children with autism: exploratory genotype–phenotype correlations , 2009, Autism research : official journal of the International Society for Autism Research.

[123]  David A. Geier,et al.  A Clinical and Laboratory Evaluation of Methionine Cycle-Transsulfuration and Androgen Pathway Markers in Children with Autistic Disorders , 2006, Hormone Research in Paediatrics.

[124]  Guoping Fan,et al.  DNA hypomethylation restricted to the murine forebrain induces cortical degeneration and impairs postnatal neuronal maturation. , 2009, Human molecular genetics.

[125]  R. Jirtle,et al.  Environmental epigenomics and disease susceptibility , 2007, Nature Reviews Genetics.

[126]  David Wallinga,et al.  A macroepigenetic approach to identify factors responsible for the autism epidemic in the United States , 2012, Clinical Epigenetics.

[127]  J. Stockman Association between Microdeletion and Microduplication at 16p11.2 and Autism , 2009 .

[128]  Christopher Gillberg,et al.  Increased rate of twins among affected sibling pairs with autism. , 2002, American journal of human genetics.

[129]  Theoharis C Theoharides,et al.  Neuro-inflammation, blood-brain barrier, seizures and autism , 2011, Journal of Neuroinflammation.

[130]  Martin Renqiang Min,et al.  An integrated encyclopedia of DNA elements in the human genome , 2012 .

[131]  Stepan Melnyk,et al.  Trans-HHS Workshop : Diet , DNA Methylation Processes and Health Elevation in S-Adenosylhomocysteine and DNA Hypomethylation : Potential Epigenetic Mechanism for Homocysteine-Related Pathology 1 , 2002 .

[132]  Dominique Bondoux,et al.  Whole blood serotonin and plasma beta-endorphin in autistic probands and their first-degree relatives , 1999, Biological Psychiatry.

[133]  Patricia M. Whitaker-Azmitia,et al.  Serotonin and brain development: role in human developmental diseases , 2001, Brain Research Bulletin.

[134]  M. Brosnan,et al.  Methylation demand: a key determinant of homocysteine metabolism. , 2004, Acta biochimica Polonica.

[135]  J. A. Laurence,et al.  Glial fibrillary acidic protein is elevated in superior frontal, parietal and cerebellar cortices of autistic subjects , 2008, The Cerebellum.

[136]  B. Seetharam,et al.  Cellular import of cobalamin (Vitamin B-12). , 1999, The Journal of nutrition.

[137]  J. Baio Prevalence of autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. , 2012, Morbidity and mortality weekly report. Surveillance summaries.

[138]  Matthew W. Mosconi,et al.  Consensus Paper: Pathological Role of the Cerebellum in Autism , 2012, The Cerebellum.

[139]  R. Waring,et al.  Sulphur metabolism in autism. , 2000 .